Effects of Taping & Exercise Therapy on Lower Back Musculoskeletal Conditions in Pakistani Patients
NCT ID: NCT05649774
Last Updated: 2023-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2022-12-14
2023-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Dry Needling and Kinesio Taping in Management of Mechanical Low Back Pain
NCT04976582
"EFFECTS OF KINESIO-TAPING ON PAIN, POSTURAL STABILITY AND FUNCTION IN PERSONS WITH DISCOGENIC LOW BACK PAIN"
NCT05713812
Myofascial Release and Joint Mobilization Therapy in Non-Specific Low Back Pain
NCT04860726
Effect of Talocrural Joint Thrust Manipulation on Mechanical Low Back Pain
NCT05475912
Effects of Bilateral Asymmetrical Limbs Proprioceptive Neuromuscular Facilitation on Multifidus Muscle in CLBP.
NCT04206137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Moreover, the investigator decided to study that which treatment protocol is better when compared to another and what is the role of sham treatment when given to the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myofascial Release (MFR)
The therapist will place its hands on the T12-L1 levels as well as on the sacrum. A cross handed hold will be performed along the fascia. Then for the gluteus Medius and maximus muscle, the therapist will stand facing the participant's leg and closed to the superior border of participant's pelvis. The therapist will place the palm of the hand on the anterior surface, allowing the fingers to rest on the outer fibers of the gluteal muscles stabilizing the pelvis of the participants. Allow the participant to flex its knee while applying adequate amount of stretch on the hip joint in an open pack position. Hold, wait for the release and stretch again. for tensor fascia Latae, The therapist will place several slightly adducted fingers of its one hand on the superior fibers proximal to the insertion on the anterior superior iliac crest and the thumb as well as the other fingers of the other hand on the distal muscle fibers. Hold, wait for the release and stretch again.
Therapy
Only Myofascial Release will be provided
Kinesio Taping (KT)
Lumbar star correction technique was applied. 4 tape I strips will be cut. The paper from the center will be torn. The targeted area will be stretched as tolerated at the lumbar region. The therapist will apply 25% to 35% tension to the strip within the therapeutic zone over the target tissue. End the strip with no tension and activate the adhesive. For the second strip change the posture in order to change the stretch on the tissue, apply the second strip with 25% to 35% tension in the center of the tape and end with no tension. Activate the adhesive. Now flex the trunk and rotate on one side. Apply the third tape strip with 25% to 35% tension in the center of the tape. Apply the fourth tape strip with flexion and rotation on the opposite side again with 25% to 35% tension on the strip.
The tape will be changed 3 times per week.
Taping technique
Only Kinesiotaping will be provided
Myofascial Release with Taping (MFKT)
Same Protocol of MFR followed by KT
Therapy with taping
Myofascial release will be provided followed by Kinesiotaping
Placebo Treatment
The control group received a sham myofascial release for 40 minutes per treatment session, three times a week for three weeks. The sham myofascial release was applied by gently placing the hands over the same areas treated in the MFR group,without sliding, just enough to maintain contact for the desired time.
SHAM
Placebo Treatment will be given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapy
Only Myofascial Release will be provided
Taping technique
Only Kinesiotaping will be provided
Therapy with taping
Myofascial release will be provided followed by Kinesiotaping
SHAM
Placebo Treatment will be given
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with nonspecific lower back pain will only be included and screened through the screening questionnaire.
Exclusion Criteria
* Females with any diagnosed co-morbidity.
* Back pain progressive to any neurological deficit
* Sustained or increased back pain with loss of appetite and unexplained weight loss accompanied with fever, nausea and chills
* With any known spinal or lower back pathology
* Tumor of the spine
* Any underlying diseases of spinal cord (i.e, ankylosing spondylosis, spondolisthesis)
* With any steroid therapy for lower back pain in the past three months
* Any inflammatory rheumatic disease
* Sensitive skin or any skin allergy or dermatological condition
* Any rehabilitative services taken for the lower back pain in the past two months
* Rejection to manual conatct
28 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Karachi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kiran Arshad
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kiran Arshad, M.Phil
Role: PRINCIPAL_INVESTIGATOR
University of Karachi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Tibri Medical college and hospital
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KArshad
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.